ArticleDermatology and therapy2026

Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

Gianluca Avallone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.